1. Home
  2. AKTS vs ICU Comparison

AKTS vs ICU Comparison

Compare AKTS & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTS
  • ICU
  • Stock Information
  • Founded
  • AKTS N/A
  • ICU 2018
  • Country
  • AKTS United States
  • ICU United States
  • Employees
  • AKTS N/A
  • ICU N/A
  • Industry
  • AKTS Telecommunications Equipment
  • ICU Biotechnology: Pharmaceutical Preparations
  • Sector
  • AKTS Utilities
  • ICU Health Care
  • Exchange
  • AKTS Nasdaq
  • ICU Nasdaq
  • Market Cap
  • AKTS 10.3M
  • ICU 10.3M
  • IPO Year
  • AKTS 2017
  • ICU N/A
  • Fundamental
  • Price
  • AKTS $0.06
  • ICU $2.17
  • Analyst Decision
  • AKTS Hold
  • ICU
  • Analyst Count
  • AKTS 1
  • ICU 0
  • Target Price
  • AKTS $1.00
  • ICU N/A
  • AVG Volume (30 Days)
  • AKTS 12.4M
  • ICU 24.8K
  • Earning Date
  • AKTS 11-19-2024
  • ICU 11-13-2024
  • Dividend Yield
  • AKTS N/A
  • ICU N/A
  • EPS Growth
  • AKTS N/A
  • ICU N/A
  • EPS
  • AKTS N/A
  • ICU N/A
  • Revenue
  • AKTS $27,384,000.00
  • ICU N/A
  • Revenue This Year
  • AKTS $42.56
  • ICU N/A
  • Revenue Next Year
  • AKTS $49.45
  • ICU $344.44
  • P/E Ratio
  • AKTS N/A
  • ICU N/A
  • Revenue Growth
  • AKTS 0.97
  • ICU N/A
  • 52 Week Low
  • AKTS $0.04
  • ICU $1.88
  • 52 Week High
  • AKTS $1.19
  • ICU $42.93
  • Technical
  • Relative Strength Index (RSI)
  • AKTS 44.20
  • ICU 21.22
  • Support Level
  • AKTS $0.04
  • ICU $1.88
  • Resistance Level
  • AKTS $0.06
  • ICU $2.81
  • Average True Range (ATR)
  • AKTS 0.01
  • ICU 0.29
  • MACD
  • AKTS 0.00
  • ICU -0.05
  • Stochastic Oscillator
  • AKTS 42.08
  • ICU 10.92

About AKTS Akoustis Technologies Inc.

Akoustis Technologies Inc is an emerging commercial product company focused on developing, designing, and manufacturing innovative RF filter solutions for the wireless industry, including for products such as smartphones and tablets, network infrastructure equipment, WiFi Customer Premise Equipment and defense applications. The company has developed a proprietary microelectromechanical system based bulk acoustic wave technology and a unique manufacturing process flow, called XBAW, for filters produced for use in RFFE modules. The company derives revenue from the sale of filter products under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product sales.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: